CD8A and Miyoshi myopathy: Additional analyses of BMMC from MM patients (newly diagnosed, relapsed, relapsed/refractory; N = 5) showed a significant (*p < 0.05) increase in proliferation of CD8+ Tc and CD4+ Th cells (CD8+ > CD4+) triggered by GAL-3 blockade (Fig. 7C).